April 9, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…
April 6, 2023 Comments Off on Drug Patent Expirations for the Week of April 2, 2023 Posted in: Uncategorized
TARGINIQ (naloxone hydrochloride; oxycodone hydrochloride) Purdue pharma lp Patent: 8,846,090 Expiration: Apr 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent E…